A discovery by Mayo Clinic researchers may help explain why immunotherapy hasn't been helpful for many patients with ...

New research shows that fecal transplants may boost the effectiveness of cancer immunotherapy drugs called PD-1 inhibitors.

While both are called medullary carcinoma, these cancers differ in many ways: ...

An internally validated simple scoring model using clinical factors successfully predicts the likelihood of detecting ...

The US Food and Drug Administration (FDA) has accepted Bristol Myers Squibb’s (BMS) supplemental biologics licence application (sBLA) for an Opdivo (nivolumab) and Yervoy (ipilimumab) combo as a first ...

A low-carb diet can worsen the cancer-causing effects of certain gut bacteria by weakening the gut barrier and altering the ...

If you’re in your 20s, 30s or early 40s, you might think you’re too young to get colon cancer. Photographer and cancer survivor Lindsey Jayn is one of those head-scratching cases.

combo as a first-line treatment for unresectable or metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) colorectal cancer (mCRC). The potential treatment is ...